These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19702629)

  • 41. Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort.
    Boulle A; Orrel C; Kaplan R; Van Cutsem G; McNally M; Hilderbrand K; Myer L; Egger M; Coetzee D; Maartens G; Wood R;
    Antivir Ther; 2007; 12(5):753-60. PubMed ID: 17713158
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Symptomatic hyperlactataemia in adults on antiretroviral therapy: a single-centre experience.
    Fabian J; Venter WD; Mkhabela L; Levin JB; Baker L; Naicker S
    S Afr Med J; 2008 Oct; 98(10):795-800. PubMed ID: 19115757
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Fatal lactic acidosis in a patient with acquired immunodeficiency syndrome treated with stavudine, lamivudine and indinavir].
    Tanaka K; Fukahori S; Jojima H; Fujimatsu Y; Shiraishi K; Tanaka M; Okubo Y; Honda J; Oizumi K
    Kansenshogaku Zasshi; 1999 Dec; 73(12):1232-5. PubMed ID: 10655686
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolic acidosis and hepatic steatosis in two HIV-infected patients on stavudine (d4T) treatment.
    Cornejo-Juárez P; Sierra-Madero J; Volkow-Fernández P
    Arch Med Res; 2003; 34(1):64-9. PubMed ID: 12604378
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reversible nucleoside analogue-associated lactic acidosis despite a prolonged course.
    Delobel P; Khatibi S; Alvarez M; Obadia M; Bonnet E; Massip P; Marchou B
    Intensive Care Med; 2003 Jun; 29(6):1028-1029. PubMed ID: 12684748
    [No Abstract]   [Full Text] [Related]  

  • 46. Prevalence, risk factors and outcome of hyperlactataemia in HIV-infected patients.
    Hocqueloux L; Alberti C; Feugeas JP; Lafaurie M; Lukasiewicz E; Bagnard G; Carel O; Erlich D; Molina JM
    HIV Med; 2003 Jan; 4(1):18-23. PubMed ID: 12534955
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HIV neuropathy risk factors and symptom characterization in stavudine-exposed South Africans.
    Wadley AL; Cherry CL; Price P; Kamerman PR
    J Pain Symptom Manage; 2011 Apr; 41(4):700-6. PubMed ID: 21145196
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of a reduced dose of stavudine on the incidence and severity of peripheral neuropathy in HIV-infected adults in South Africa.
    Pahuja M; Grobler A; Glesby MJ; Karim F; Parker G; Gumede S; Naidoo K
    Antivir Ther; 2012; 17(4):737-43. PubMed ID: 22414588
    [TBL] [Abstract][Full Text] [Related]  

  • 49. L-Carnitine as a treatment of life-threatening lactic acidosis induced by nucleoside analogues.
    Claessens YE; Cariou A; Chiche JD; Dauriat G; Dhainaut JF
    AIDS; 2000 Mar; 14(4):472-3. PubMed ID: 10770558
    [No Abstract]   [Full Text] [Related]  

  • 50. A longitudinal study of stavudine-associated toxicities in a large cohort of South African HIV infected subjects.
    Menezes CN; Maskew M; Sanne I; Crowther NJ; Raal FJ
    BMC Infect Dis; 2011 Sep; 11():244. PubMed ID: 21923929
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hyperlactataemia during antiretroviral therapy: incidences, clinical data and treatment.
    Gérard Y; Viget N; Yazdanpanah Y; Ajana F; de La Tribonnière X; Bocket L; Deuffic-Burban S; Dos Santos A; Ballester L; Mouton Y
    Therapie; 2003; 58(2):153-8. PubMed ID: 12942856
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety of stavudine in the treatment of HIV infection with a special focus on resource-limited settings.
    Makinson A; Moing VL; Kouanfack C; Laurent C; Delaporte E
    Expert Opin Drug Saf; 2008 May; 7(3):283-93. PubMed ID: 18462186
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lactic acidosis in the setting of antiretroviral therapy for the acquired immunodeficiency syndrome. A case report and review of the literature.
    Shaer AJ; Rastegar A
    Am J Nephrol; 2000; 20(4):332-8. PubMed ID: 10970989
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatic steatosis and lactic acidosis caused by stavudine in an HIV-infected patient.
    Bleeker-Rovers CP; Kadir SW; van Leusen R; Richter C
    Neth J Med; 2000 Nov; 57(5):190-3. PubMed ID: 11063865
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hyperlactataemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factors.
    Moyle GJ; Datta D; Mandalia S; Morlese J; Asboe D; Gazzard BG
    AIDS; 2002 Jul; 16(10):1341-9. PubMed ID: 12131210
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Symptomatic hyperlactataemia: an emerging complication of antiretroviral therapy.
    Gérard Y; Maulin L; Yazdanpanah Y; De La Tribonnière X; Amiel C; Maurage CA; Robin S; Sablonnière B; Dhennain C; Mouton Y
    AIDS; 2000 Dec; 14(17):2723-30. PubMed ID: 11125891
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fatal toxicity from symptomatic hyperlactataemia: a retrospective cohort study of factors implicated with long-term nucleoside reverse transcriptase inhibitor use in a South African hospital.
    Leung L; Wilson D; Manini AF
    Drug Saf; 2011 Jun; 34(6):521-7. PubMed ID: 21488705
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Longitudinal lactate levels from routine point-of-care monitoring in adult Malawian antiretroviral therapy patients: associations with stavudine toxicities.
    Chagoma N; Mallewa J; Kaunda S; Njalale Y; Kampira E; Mukaka M; Heyderman RS; van Oosterhout JJ
    Trans R Soc Trop Med Hyg; 2013 Oct; 107(10):615-9. PubMed ID: 23926161
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Symptomatic hyperlactataemia and lactic acidosis in the era of highly active antiretroviral therapy.
    Eshun-Wilson I; Soentjens P; Zeier M; Taljaard J
    S Afr Med J; 2005 Dec; 95(12):929-30. PubMed ID: 16465351
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical assessment of peripheral neuropathy in HIV-infected children on antiretroviral therapy in rural South Africa.
    Peters RP; Van Ramshorst MS; Struthers HE; McIntyre JA
    Eur J Pediatr; 2014 Sep; 173(9):1245-8. PubMed ID: 24691679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.